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Abstract
Background: Both epidemiological and experimental studies suggest that heterozygosity for a single gene is
linked with tumorigenesis and heterozygosity for two genes increases the risk of tumor incidence. Our previous
work has demonstrated that Atm/Brca1 double heterozygosity leads to higher cell transformation rate than single
heterozygosity. However, the underlying mechanisms have not been fully understood yet. In the present study, a
series of pathways were investigated to clarify the possible mechanisms of increased risk of tumorigenesis in Atm
and Brca1 heterozygosity.
Methods: Wild type cells, Atm or Brca1 single heterozygous cells, and Atm/Brca1 double heterozygous cells were
used to investigate DNA damage and repair, cell cycle, micronuclei, and cell transformation after photon irradiation.
Results: Remarkable high transformation frequency was confirmed in Atm/Brca1 double heterozygous cells
compared to wild type cells. It was observed that delayed DNA damage recognition, disturbed cell cycle
checkpoint, incomplete DNA repair, and increased genomic instability were involved in the biological networks.
Haploinsufficiency of either ATM or BRCA1 negatively impacts these pathways.
Conclusions: The quantity of critical proteins such as ATM and BRCA1 plays an important role in determination of
the fate of cells exposed to ionizing radiation and double heterozygosity increases the risk of tumorigenesis. These
findings also benefit understanding of the individual susceptibility to tumor initiation.
Keywords: heterozygosity, haploinsufficiency, tumorigenesis, DNA damage, cell cycle checkpoint, genomic
instability
Background
Heterozygosity leads to haploinsufficiency for proteins.
Heterozygous animals for one gene show similar appear-
ance and life-span as the wild type in normal conditions
since one of the alleles is still functional. However, het-
erozygous animals display high tumor incidence when
exposed accidentally and severely to mutagens, such as
high doses of ionizing radiation. It has been reported
that Pten haploinsufficiency accelerated formation of
astrocytomas and CDKN1B (also known as p27/Kip1 )
haploinsufficiency contributed to leukemogenesis [1,2].
In general case, an individual may carry more than one
heterozygous gene. Heterozygosity for two or more
genes may multiply the risk of tumor initiation [3-5].
Double heterozygosity of Pten/Trp53 accelerated pro-
static tumorigenesis [6]. A strong enhancement in mam-
mary carcinogenesis by Atm/p53 double heterozygosity
has also been reported [7].
It was found that genes critical for DNA damage signal-
ing and repair pathways play an important role in tumori-
genesis of heterozygosity [8-11]. ATM is both a sensor
and transducer of DNA damage. The protein is rapidly
activated by damage-induced autophosphorylation on
ser
1981 followed by dissociation into an active monomer
[12,13]. Once activated, it phosphorylates a series of down-
stream substrates including Nbs1, Chk1, Chk2, p53, etc.,
and finally activates cell cycle checkpoints, DNA repair as
well as apoptosis [14]. It has been reported that Atm het-
erozygosity is linked with the induction of cataracts and
tumorigenesis [15-18]. BRCA1 is also a multifunctional
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tral role in DNA repair [19,20]. The protein reduces the
expression, phosphorylation and cellular localization of
cdc25c and cdc2/cyclinB kinase, increases the expression
of Wee1 kinase and 14-3-3s to inhibit the G2-M transi-
tion. People who are heterozygous for Brca1 h a v eah i g h
risk of developing breast and ovarian cancer [21]. Contri-
bution of Brca1 heterozygosity to tumor susceptibility has
been reported [22,23].
In some cases, a multifunctional gene may be involved
in more than one pathway when cells are exposed to exo-
genous stress. This makes the mechanisms of heterozyg-
osity-related tumorigenesis more complicated. For
example, both ATM and BRCA1 are part of BASC
(BRCA1-associated genome surveillance complex), which
is involved in recognition and repair of aberrant DNA
structures [24,25]. DNA damage-induced ATM activa-
tion requires a coordinated assembly of BRCA1, BAAT1,
and ATM [26], meanwhile BRCA1 is a substrate of ATM
and its phosphorylation by ATM is critical for respond-
ing to double-strand breaks and G2/M checkpoint
[27-29]. Epidemiological statistics reveals that reduction
of ATM is common in BRCA1/2-deficient breast cancer
[30]. Breast cancer in AT family is 1.5-14 folds higher
[31-34]. Therefore, ATM and BRCA1 interact with each
other and their association could be enhanced by muta-
gen treatment. Both of Atm and Brca1 are multifunc-
tional genes involved in DNA repair pathways and cell
cycle checkpoints. The risk of tumorigenesis may be
increased in Atm/Brca1 double heterozygote.
Up to now, there are very few literatures on Atm/
Brca1 double heterozygosity and their contribution to
tumor initiation. In 2005, Bowen et al.r e p o r t e dt h a t
Atm heterozygosity increased the severity of mammary
gland tumors in the BRCA1-defficient mouse [35]. Our
previous work has demonstrated that double heterozyg-
osity for Atm and Brca1 leads to higher cell transforma-
tion rate than single heterozygosity [36], but the
underlying mechanisms have not been fully understood
yet. In the present study, mouse embryonic fibroblast
(MEF) cells of wild type, Atm or Brca1 single heterozyg-
osity, and Atm/Brca1 double heterozygosity were used
to develop the correlation of heterozygosity for Atm
and/or Brca1 and tumorigenesis. A series of pathways
including DNA damage recognition and repair, cell
cycle checkpoints, genomic instability, and transforma-
tion frequency were investigated to identify the possible
underlying mechanisms after the four genotypes of cells
were exposed to photon radiation.
Methods
Cell culture
Four genotypes of MEF cells (wild type, ATMwt/
BRCA1wt; Atm single heterozygote, ATMhz/BRCA1wt;
Brca1 single heterozygote, ATMwt/BRCA1hz; and Atm/
Brca1 double heterozygote, ATMhz/BRCA1hz) were
obtained from the Center for Radiological Research,
Columbia University Medical Center, New York. Cells
were cultured with DMEM high glucose (Gibco, Grand
Island, NY, USA) supplemented with 15% FBS
(HyClone, Logan, UT, USA).
Irradiation
A GammaCell 40
137Cs irradiator (0.82 Gy/min) of
Columbia University and a 6 MV X-ray generator (2
Gy/min) of Gansu Academy of Medical Sciences were
used for the irradiation of the cells.
Cell survival and neoplastic transformation
Anchorage-independent growth was conducted as
described previously with slight modification [37]. Neo-
plastic transformation was assessed in a non-permissive
condition of soft agar. Briefly, j60 mm dishes were pre-
viously plated with 8 ml base agar layer prepared from a
mixture of 68 ml 1.25% Bacto-agar, 17 ml tryptose phos-
phate broth (Sigma, St. Louis, MO, USA), 17 ml FBS and
68 ml double-strength of DMEM medium. After the mix-
ture was solidified, 2.0 × 10
4 cells which had been
exposed to 2 Gy of photons and incubated for one week
were added to 2 ml of agar mixture prepared as above,
and then plated on the agar base. Immediately after plat-
ing, cell clumps in each dish were marked and scored to
avoid mis-counted as colonies. Cells were grown for 2
months in a CO2 incubator with saturated humidity.
During this period 1 ml medium were added periodically
to each dish. Colonies were counted as transformants
using a dissecting microscope. For cell survival, similar
procedure was followed but in a permissive condition.
Specifically, 1.25% Bacto-agar was replaced with low-
melting-point agarose and tryptose phosphate broth was
replaced with distilled water. Cell survival was assessed
right after cells were exposed to irradiation.
gH2AX foci
Exponentially growing MEF cells of four genotypes were
plated in four-well slide chambers (Lab-Tek, Naperville,
IL, USA) at a density of 8 × 10
3 cells/well. Sixteen hours
later, the cells were irradiated with 0.2 and 0.5 Gy of
photons, fixed for 10 min in 4% paraformaldehyde, per-
meabilized for 5 min in methanol at -20°C, blocked for
1 h with 5% skim milk, and stained with mouse anti-
gH2AX antibody (Upstate Biotechnology, Lake Placid,
NY, USA) for 2 h. The bound antibody was visualized
using Alexa Fluor
® 488 anti-mouse antibody (Molecular
Probes, Eugene, OR, USA), and cell nuclei were coun-
terstained with PI/RNase solution (PharMingen, San
Jose, CA, USA). Slides were observed under a confocal
laser scanning microscope (Nikon, Tokyo, Japan). At
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average number of foci per cell was calculated.
Comet Assay
DNA damage and repair were evaluated with alkaline
comet assay according to the report of Olive et al with
minor modifications [38]. In brief, single cells were
harvested and re-suspended in DMEM medium con-
taining 10% FBS at a concentration of 1 × 10
6 cells/ml.
Cell suspension was mixed with 0.5% low melting-
point agarose (Amresco, Solon, OH, USA) (1:3, V/V).
The mixture was layered on each glass slide with pre-
coated 0.5% LE agarose. After exposed to 10 Gy of
photons, the samples were gently immersed into
freshly prepared lysis solution (2.5 M NaCl, 10 mM
Tris, 1% sodium lauryl sarcosinate, 100 mM EDTA, 1%
Triton-100, and 10% DMSO) for 1.5 h and transferred
to electrophoresis tank. After 20 min of DNA unwind-
ing in buffer (1 mM EDTA, 300 mM NaOH, pH > 13),
electrophoresis was performed in the same buffer (20
min, 20 V, 300 mA). The samples were neutralized
with 0.4 M Tris-HCl (pH 7.5) and air-dried after a
brief fixation with 70% ethanol.
Individual cells were visualized with ethidium bromide
staining and photographed under a fluorescence micro-
scope. For each sample, 200 comets were analyzed with
CASP software [39].
Cell cycle
Cell cycle distribution was monitored with a flow cyt-
ometer as described previously [40]. MEF cells exposed
to 5 Gy of photons were post-incubated for various
times, harvested, fixed with 70% pre-chilled ethanol for
over 24 h at -20°C, re-suspended in PBS, and treated
with PI/RNase solution. Cell cycle distribution of 10,000
cells for each genotype was analyzed with CellQuest
pre-stored in FACScan flow cytometer (Beckon-Dickin-
son, CA, USA).
Micronuclei
Exponentially growing MEF cells of four genotypes were
plated in 12-well plates at a density of 3 × 10
5 cells/well.
For each well, 3 μg/ml of cytochalasin B (Sigma, St. Louis,
MO, USA) was added after cells were exposed to 2 Gy of
photons. Twenty-four hours later, cells were washed with
PBS and fixed with methanol-glacial acetic acid (9:1, V/V).
After stained with 3 μg/ml Acridine Orange, at least 500
of binucleated cells for each genotype were counted to
obtain the frequency of micronuclei.
Statistical Analysis
All data were presented as mean ± SE of at least three
independent experiments. Students’ t-test was used to
evaluate statistically significant.
Results
Transformation
Anchorage-independent growth assay was carried out to
measure cell survival of four kinds of MEF cells in per-
missive condition right after the cells were exposed to 2
Gy of photons and to measure neoplastic transformation
in non-permissive condition 1 week after irradiation.
Results showed that 2 Gy of photons inactivated the
four kinds of MEF cells almost equally (Figure 1A).
However, induced cell transformation was in a geno-
type-dependent manner (Figure 1B). For sham irradiated
sample, an average transformation frequency of 8.86 ±
0.14, 6.31 ± 1.66, 8.69 ± 1.35, and 10.50 ± 1.64 (× 10
-5,
transformants per 10
5 viable cells) was obtained for
ATMwt/BRCA1wt, ATMwt/BRCA1hz, ATMhz/
BRCA1wt, and ATMhz/BRCA1hz, respectively. No sig-
nificant differences were observed. Upon photon irradia-
tion, dramatically increased yields of anchorage-
independent colonies were observed in the four kinds of
cells in a genotype-dependent manner. Remarkably high
transformation frequency was obtained in double het-
erozygous cells while wide type cells presented the low-
est transformation frequency and single heterozygous
cells presented the middle ones. This result confirms
that double heterozygosity is confronted with higher
tumorigenesis risk than single one.
DNA damage and repair
In this study, we used two methods to observe DNA
damage and repair ability of cells heterozygous for Atm
and/or Brca1.O n ew a sgH2AX focus formation by
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Figure 1 Anchorage-independent growth levels of four kinds
of MEF cells. After cells were exposed to 2 Gy of photons,
permissive soft-agar assay was performed immediately to assess cell
survival (Panel A) and 1 week later, non-permissive soft-agar assay
were performed to assess neoplastic transformation (Panel B).
Transformants were visually scored under a dissecting microscope.
Data are from four independent experiments. * indicates the
significant difference (p < 0.05) compared with ATMwt/BRCA1wt
cells and ^ indicates the significant difference (p < 0.05) compared
with ATMwt/BRCA1hz cells experienced the same treatment.
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Page 3 of 8immunofluorescent staining to visualize DSBs [41] and
t h eo t h e rw a sa l k a l i n ec o m e ta s s a yt oq u a n t i f yt o t a l
DNA damage.
Representative pictures of gH2AX foci were shown as
Figure 2. Consistent with other reports, gH2AX foci
were formed in a dose- and time- dependent manner
( F i g u r e3 ) .T h ed o s er e s p o n s eo fgH2AX focus forma-
tion was scored at 30 min post-irradiation. The foci per
cell induced by 0.5 Gy of photons did not show statisti-
cal differences in all kinds of MEF cells. However, signif-
icant differences were observed when cells were exposed
to 0.2 Gy of photons. The lowest number was in double
heterozygous cells. This genotype-dependent manner
was confirmed by the kinetics of focus formation. The
number of gH2AX foci increased very rapidly after irra-
d i a t i o ne v e nd u r i n gt h ev e r yf i r s t2m i nr e q u i r e df o r
sample preparation. The number of foci in wild type
cells reached to the maximum at 15 min and then
decreased gradually. Atm single heterozygous cells,
Brca1 single heterozygous cells and Atm/Brca1 double
heterozygous cells spent as long as 60 min before the
approach to the maximum. It indicates that the response
of wild type cells to DSBs induced by ionizing radiation
is faster than the response of heterozygous cells. The
recognition of DNA damage is delayed in heterozygote.
In previous studies, we observed significantly higher
background of DNA damage in heterozygous cells [36].
We observed the induction and repair of DNA damage
Figure 2 Representative pictures of gH2AX foci. Cells were exposed to 0.5 Gy of photons and stained with mouse anti-gH2AX antibody
visualized by Alexa Fluor
® 488 anti-mouse antibody and propidium iodide (PI) at 15 and 1440 min post-irradiation.
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same technology, comet assay. As shown in Figure 4,
without post-irradiation incubation, DNA damage
induced in wild type cells was significantly lower than
that in other three kinds of cells (p < 0.01). It might be
due to the rapid repair processes that occurred during
comet assay preparation. At 240 min post-incubation,
DNA damage in each cell type decreased to background
level. However, the residual DNA damage in double het-
erozygous cells was the highest one among the four
kinds of MEF cells, and the residual DNA damages in
single heterozygote were also significantly higher than
that in wild type cells. These results suggest that DNA
repair may be delayed in heterozygote and DNA repair
ability may be the lowest in double heterozygote.
Cell cycle dynamics
As expected, 5 Gy of photons induced G2/M block in all
genotypes. Notably the induction of G2/M block was
similar in all the genotypes (Figure 5). However, different
genotypes followed different dynamics of G2/M-phase
cell release. Wild type cells overcame the G2/M arrest in
13 hours. Brca1 single heterozygous cells overcame that
block earlier while Atm single heterozygous cells later.
Interestingly, single heterozygosity results in disturbed
cell cycle control while double heterozygous cells showed
a similar cell cycle dynamics to the wild type cells.
Genomic instability
Cytochalasin-blocked micronucleus assay is a widely
used method for the detection of genomic instability.
The micronuclei per binucleated cell induced by 2 Gy of
photon in each kind of cells were not the same (Figure
6). The highest micronucleus frequency was observed in
double heterozygous cells while the lowest in wild type
cells. This result demonstrates that micronucleus forma-
tion can be obviously enhanced in Atm/Brca1 double
heterozygous cells, suggesting an impairing of genomic
stability.
Discussion
Heterozygosity results in haploinsufficiency. Haploinsuf-
ficient animals or cells for DNA-repair related proteins
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Figure 4 Total DNA damage measured with alkaline comet
assay in four kinds of MEF cells at different time course. Data
were a pool of three independent experiments and totally 200 cells
were scored. * and ** indicate the significant difference compared
with ATMwt/BRCA1wt cells experienced the same treatment and
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Figure 5 Cell cycle distribution in MEF cells exposed to 5 Gy of
photons. Kinetics of G2/M block based on original data (Panel A)
and optimized dada in which the control level of G2/M-phase cells
was correspondingly subtracted from the proportion of G2/M-phase
cells of each sample (Panel B). Data are pooled from three
independent experiments.
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high tumor incidence or transformation rate is observed
when they are exposed severely and accidentally to exo-
genous stimuli. It is very possible that protein products
from one allele are not enough for the detection and
repair of damage induced by the exogenous factors. On
the other hand, cell cycle checkpoint is activated to earn
time for damage repair. If the heterozygous gene takes
part in the cell cycle checkpoint pathway, cell cycle
checkpoint might also be negatively impacted and cells
with un-repaired damage might escape the monitor and
pass the remained lesions to their daughter cells, which
have high potential for genomic instability, transforma-
tion, and consequently high risk of tumorigenesis.
How does haploinsufficiency impact the processes of
DNA damage recognition?
In 2006, Smilenov proposed a theory of temporal biolo-
gical network to explain the mechanisms underlying the
link between heterozygous Atm and/or Rad9 and tumor
predisposition, in which a temporal network assembled
by both gene products and DNA damage caused by
ionizing radiation is thought to be critical to activate
apoptosis pathways [42]. According to this theory,
ATM-dependent local network is a critical element in a
cell responding to DNA damage. The number of local
networks assembled on the damage points determines
the generated signal level, which in turn controls the
induction of apoptosis. Theoretically, there is no pro-
blem for wide type cells to recognize DNA damage
induced by high-dose and low-dose radiation. In the
case of heterozygosity and high-dose radiation, heterozy-
gous cells can recognize DNA damage due to enough
DNA damage even though there are no enough gene
products to work efficiently. However, in the case of
heterozygosity and low-dose radiation, since neither
gene products nor DNA damage is enough, limited
number of local networks might be assembled to trigger
apoptosis. Some of the damages will not be detected,
and apoptotic response can not be fully activated. Het-
erozygous cells with lesions might survive the stimula-
tion, which consequently results in tumor initiation.
In the present study, we employed gH2AX foci to
observe the DNA recognition because it is a rapid pro-
cess and sensitive method. After irradiation, gH2AX foci
usually appear in 30 seconds and increase until a plateau
is reached by 10-30 minutes [43]. The level of the pla-
teau is proportional to radiation dose [44]. Along with
further incubation, the number of foci per cell decreases
due to DNA repair. Therefore, the height of plateau
may reflect the original damage level, and the formation
process of gH2AX foci may represent the recognition of
DNA damage. As shown in Figure 3, the genotype-
dependent difference of gH2AX foci implied that some
DNA damage induced by 0.2 Gy photons could not be
well recognized in double heterozygosity. Furthermore,
it took heterozygous cells longer time to respond to
radiation as confirmed by the time kinetics. Thus, Sim-
lenov’s hypothesis can be broadened to more biological
processes. In the case of heterozygosity and low-dose
radiation, no enough temporary biological networks are
assembled to activate a series of pathways, such as
damage recognition, DNA repair, apoptosis, and so on.
Double heterozygosity leads to the alleviated assembly
of local networks. One possible pathway of those hetero-
zygous cells with un-repaired damage is to go to repro-
ductive death, and another is to escape from cell cycle
monitoring, apoptosis pathway, and consequently trans-
fer the lesions to daughter cells through mitosis.
How does haploinsufficiency impact cell cycle
checkpoints?
ATM activates a series of DNA-repair related factors
[27] and cell cycle checkpoints factors [14,45]. BRCA1 is
one of the key proteins participating in a common path-
way to facilitate orderly homologous recombination and
thereby maintaining genomic stability [20]. Therefore,
insufficient products of these two genes supposedly lead
to incompletely functional cell cycle checkpoints.
In our experiments, Atm-knockout cells have a high
proportion of G2/M phase, which is in consistent with
the other report [46]. As shown in Figure 5, Atm knock-
out cells exposed to 5 Gy of photons had prolonged G2
arrest, which implies the important role of ATM in G2-
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Figure 6 Induction of micronuclei in MEF cells exposed to 2 Gy
of photons. Individual cells were visualized with Acridine Orange
staining and micronuclei (MN) per binucleated cell (BN) were score
under fluorescence microscope. More than 500 BN cells were
counted for each sample. Data were pooled from three
independent experiments. * indicates the significant difference (p <
0.05) compared with ATMwt/BRCA1wt cells exposed to the same
dose of photons.
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the delay of G2-arrest release in cells heterozygous for
Atm? Since ATM is a sensor detecting DNA damage
and also a transducer activating downstream genes to
repair the damage, its insufficient expression theoreti-
cally reduces the efficiency of DNA repair. The extra
repair time obtained from the prolonged G2 arrest
could not compensate this inefficiency, which can be
concluded from the results of DNA repair measured by
alkaline comet assay. As shown in Figure 4, the wild
type cells have the most efficient repair ability, and the
double heterozygote has the least. On the other hand, a
very possible consequence of the abrogation of G2 arrest
in cells heterozygous for Brca1 is that some cells with
un-repaired DNA damage escape the cell cycle monitor-
ing and transfer the damage to their offspring.
Atm and Brca1 heterozygosity enhances transformation
frequency and increases the risk of tumorigenesis
Since Atm/Brca1 double heterozygosity results in low
apoptosis [36], a very possible consequence is that resi-
dual DNA damage escaped from cell cycle checkpoints
arouses genomic instability in the offspring of heterozy-
gous cells. As shown in Figure 6, micronuclei induced
by photons were genotype-dependent. The highest
micronucleus frequency was obtained in double hetero-
zygote while the lowest in wild type cells.
High sensitivity to transformation and low level of
DNA damage repair were reported in double heterozy-
gote induced by radiation [36, 47 and 48]. Our results
confirmed that heterozygosity of either Atm or Brca1
resulted in increased cell transformation and Atm/Brca1
double heterozygosity enhanced the transformation fre-
quency significantly (Figure 1).
These results imply the positive correlation of geno-
mic instability with cell transformation and the conse-
quently high frequency of tumor initiation in double
heterozygote.
Conclusions
Taken together, haploinsufficiency of either ATM or
BRCA1 negatively impacts a series of pathways includ-
ing delayed DNA damage recognition, disturbed cell
cycle checkpoint, incomplete DNA repair, increased
genomic instability and transformation frequency. The
quantity of critical proteins such as ATM and BRCA1
plays an important role in determination of the fate of
cells exposed to ionizing radiation and Atm/Brca1 dou-
ble heterozygosity increases the risk of tumorigenesis.
These findings not only provide an experimental proof
to Smilenov’s hypothesis and broaden it to more biolo-
gical processes, but also benefit understanding of the
individual susceptibility to tumor initiation.
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